BIOPHARM FORWARD ApS
CVR 32438784 · Private limited company (ApS) · Active · Low risk
BIOPHARM FORWARD ApS is a Private limited company (ApS), founded on , based in Espergærde. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 16 annual reports have been published. The latest annual report (25 Aug 2025) shows equity of DKK 1.7m and a net result of DKK 244k. CEO: Jonas Hink.
Bankruptcy risk for BIOPHARM FORWARD ApS
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32438784
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (17 years)
- Address
- c/o Hink, Gammel Strandvej 442A, st. th
3060 Espergærde - Municipality
- Helsingør
- Industry
- Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. - Share capital
- DKK 131k
- Employees
- 0 (2011)
- Auditor
- Vedbæk Revision, Registreret revisionsfirma FSR
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 77.6% |
| Current ratio | 517% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 997k | DKK 1.1m |
| Net profit | DKK 244k | DKK 385k |
| Equity | DKK 1.7m | DKK 1.6m |
| Total assets | DKK 2.2m | DKK 2.1m |
| Cash | DKK 1.9m | – |
| Short-term debt | DKK 435k | – |
| Tax owed | DKK 78k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Vedbæk Revision, Registreret revisionsfirma FSR.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 26 Aug 2024 – 25 Aug 2025 | 170 | ||
| 26 Aug 2023 – 25 Aug 2024 | 155 | ||
| 26 Aug 2022 – 25 Aug 2023 | 177 | ||
| 26 Aug 2021 – 25 Aug 2022 | 175 | ||
| 26 Aug 2020 – 25 Aug 2021 | 135 | ||
| 26 Aug 2019 – 25 Aug 2020 | 161 | ||
| 26 Aug 2018 – 25 Aug 2019 | 144 | ||
| 26 Aug 2017 – 25 Aug 2018 | 118 | ||
| 26 Aug 2016 – 25 Aug 2017 | 168 | ||
| 26 Aug 2015 – 25 Aug 2016 | 141 | ||
| 26 Aug 2014 – 25 Aug 2015 | 138 | ||
| 26 Aug 2013 – 25 Aug 2014 | 144 | ||
| 26 Aug 2012 – 25 Aug 2013 | 149 | ||
| 26 Aug 2011 – 25 Aug 2012 | 160 | ||
| 26 Aug 2010 – 25 Aug 2011 | 151 | ||
| 26 Aug 2009 – 25 Aug 2010 | 113 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jonas Hink | Current | |
| CEO | Jonas Hink | ||
| CEO | Bodil Elisabeth Fransiska Ørkild | ||
| CEO | Jonas Hink | ||
| CEO | Bodil Elisabeth Fransiska Ørkild | ||
| Owner (100%) | Jonas Hink | Current | |
| Founder | Jonas Hink | Current |
Address history (3 moves)
| c/o Hink, Gammel Strandvej 442A, st. th, 3060 Espergærde | |
| c/o Hink, Humlebæk Strandvej 131, 3050 Humlebæk | |
| Agern Alle 3, 2970 Hørsholm | |
| c/o Jonas Hink, Humlebæk Strandvej 131, 3050 Humlebæk |
Employees per year
Other companies at the same address
- HEALTH CLINIC ApS Opløst
- Mottlau Consulting ApS Active
- Mottlau Holding Aps Active
Similar companies in Helsingør
- FALKEN INVEST ApS Hornbæk
- Sunde Løsninger ApS Helsingør
- Pixel Platform ApS Hellebæk
- German Tornado ApS Espergærde
- RevX ApS Espergærde
- Flow Rekruttering ApS Helsingør
- Kiox Pharmaceuticals ApS Snekkersten
- ThoboHauth Trading ApS Hornbæk
- Noorbyg ApS Hornbæk
- THINK SMART ApS Espergærde
- P. MØRK ApS Espergærde
- ERIK W HOLDING ApS Helsingør
Questions and answers about BIOPHARM FORWARD ApS
Has BIOPHARM FORWARD ApS gone bankrupt?
No, BIOPHARM FORWARD ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIOPHARM FORWARD ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of BIOPHARM FORWARD ApS?
Jonas Hink is the CEO of BIOPHARM FORWARD ApS.
Who is the auditor of BIOPHARM FORWARD ApS?
BIOPHARM FORWARD ApS most recently used Vedbæk Revision, Registreret revisionsfirma FSR.
When was BIOPHARM FORWARD ApS founded?
BIOPHARM FORWARD ApS was founded on 26 August 2009.
What is the equity of BIOPHARM FORWARD ApS?
Equity was DKK 1.7m according to the annual report for the period ending 25 August 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.